Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells

被引:77
作者
Thomson, L
Blaylock, MG
Sexton, DW
Campbell, A
Walsh, GM
机构
[1] Univ Aberdeen, Dept Med & Therapeut, Sch Med, Aberdeen AB25 2ZD, Scotland
[2] UCB Farchim SA, Bulle, Switzerland
关键词
cetirizine; eosinophil; eotaxin; levocetirizine; transendothelial migration;
D O I
10.1046/j.1365-2745.2002.01444.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
Background Several second-generation antihistamines have documented anti-inflammatory effects which appear independent of H-1-receptor blockade. We investigated the inhibitory effect of cetirizine and its active enantiomer levocetirizine on eosinophil transendothelial migration (TEM) through monolayers of normal human dermal microvascular endothelial cells (HMVEC-d) or human lung microvascular endothelial cells (HMVEC-l). Methods HMVEC-d or HMVEC-l were grown to confluence on micropore filters in transwells inserted into a 24-well tissue culture dish. Eosinophils were isolated by density gradient centrifugation and negative immunomagnetic selection. Untreated eosinophils or eosinophils pre-incubated (30 min at 37 degreesC) with a concentration range of cetirizine or levocetirizine (10(-5) to 10 (-9) m) were added to the upper chamber of the transwell which was incubated for 60 min at 37 degreesC. Both spontaneous eosinophil TEM and TEM to 100 ng/mL of human eotaxin in the lower chamber were assessed. Results Between 8 and 10% of the eosinophils added to the upper chamber underwent spontaneous TEM through HMVEC-d or HMVEC-l. The addition of eotaxin to the lower chamber enhanced eosinophil TEM through HMVEC-d or HMVEC-l monolayers to over 20%, i.e. an enhanced TEM of approximately 100% in each case. Pre-incubation of eosinophils with cetirizine or levocetirizine dose-dependently inhibited eosinophil TEM to eotaxin through both HMVEC-d or HMVEC-l with total inhibition of eotaxin-induced TEM observed at 10(-8) m for HMVEC-d and 10(-7) m for HMVEC-l. Both drugs gave a reduced but significant inhibition of eosinophil TEM at lower concentrations. No concentration of cetirizine or levocetirizine had any significant effect on expression of CD11b, CD18 or CD49d by either resting or eotaxin-stimulated eosinophils. Furthermore, no effect on spontaneous eosinophil TEM, or eosinophil viability was seen with any concentration of cetirizine or levocetirizine. Conclusion Levocetirizine inhibits eotaxin-induced eosinophil TEM through both dermal and lung microvascular endothelial cells suggesting that, like cetirizine, levocetirizine has potential anti-inflammatory effects.
引用
收藏
页码:1187 / 1192
页数:6
相关论文
共 33 条
[1]
Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549) [J].
Arnold, R ;
Rihoux, JP ;
König, W .
CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (12) :1681-1691
[2]
Ligation of CD45 and the isoforms CD45RA and CD45RB accelerates the rate of constitutive apoptosis in human eosinophils [J].
Blaylock, MG ;
Sexton, DW ;
Walsh, GM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) :1244-1250
[3]
Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells [J].
BurkeGaffney, A ;
Hellewell, PG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 227 (01) :35-40
[4]
EFFECT OF CETIRIZINE ON MAST CELL-MEDIATOR RELEASE AND CELLULAR TRAFFIC DURING THE CUTANEOUS LATE-PHASE REACTION [J].
CHARLESWORTH, EN ;
KAGEYSOBOTKA, A ;
NORMAN, PS ;
LICHTENSTEIN, LM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (05) :905-912
[5]
Non-H1-receptor effects of antihistamines [J].
Church, MK .
CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 :39-48
[6]
CHURCH MK, 1996, CLIN ALLERGY IMMUNOL, P117
[7]
A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers [J].
Devalia, JL ;
De Vos, C ;
Hannotte, F ;
Baltes, E .
ALLERGY, 2001, 56 (01) :50-57
[8]
EBISAWA M, 1992, J IMMUNOL, V149, P4021
[9]
H-1-RECEPTOR ANTAGONISTS - COMPARATIVE TOLERABILITY AND SAFETY [J].
ESTELLE, F ;
SIMONS, R .
DRUG SAFETY, 1994, 10 (05) :350-380
[10]
INVIVO EFFECTS OF CETIRIZINE ON CUTANEOUS REACTIVITY AND EOSINOPHIL MIGRATION INDUCED BY PLATELET-ACTIVATING FACTOR (PAF-ACETHER) IN MAN [J].
FADEL, R ;
DAVID, B ;
HERPINRICHARD, N ;
BORGNON, A ;
RASSEMONT, R ;
RIHOUX, JP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (03) :314-320